Anna Sicuranza

13PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 27, 2026
Prognostic Value of Semi-Quantitative Metabolic Parameters on [18F]FDG PET/CT in Patients with Diffuse Large B-Cell Lymphoma at Diagnosis.

|Jul 19, 2026
Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm.

|Mar 26, 2026
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM.

Alessandro Gozzetti, Paola Pacelli, Federico Caroni

|Dec 10, 2025
Reply to "Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!"

Anna Sicuranza, Paola Pacelli, Adele Santoni

|Oct 15, 2025
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study.

Anna Sicuranza, Paola Pacelli, Adele Santoni

|May 07, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.

Anna Sicuranza, Massimo Breccia, Francesco Iuliano

Pageof 3

Frequent Collaborators

10 joint publications

Monica Bocchia

4 joint publications

Paola Pacelli

3 joint publications

Elisabetta Abruzzese

3 joint publications

Donatella Raspadori